Results 181 to 190 of about 138,522 (216)

No-Flow Duration and Outcomes After Cardiogenic Out-of-Hospital Cardiac Arrest in Older Adults.

JAMA Netw Open
Kishihara Y, Kashiura M, Yasuda H, Amagasa S, Tamura H, Nakajima C, Shiraoka Y, Okubo M, Moriya T.   +8 more
europepmc   +1 more source

Atypical Presentation of Massive Pulmonary Embolism Leading to In-Hospital Cardiac Arrest and Successful Thrombolysis. [PDF]

Cureus
Sadiq H, Abdul Hameed F, Jenifer A, Lamichhane S, Husain MM.   +4 more
europepmc   +1 more source

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). II. Treatments in more advanced clinical development

Epilepsia, EarlyView.
Abstract This article summarizes data for 13 investigational treatments for which at least preliminary seizure outcome data in patients with epilepsy were reported at the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices held in Madrid, Spain, on May 3–6, 2026.
Meir Bialer, Cecilie Johannessen Landmark, Matthias J. Koepp, Emilio Perucca, Piero Perucca, Torbjörn Tomson, H. Steve White, Elaine Wirrell   +7 more
wiley   +1 more source

BMIPP Imaging in Out-of-Hospital Cardiac Arrest: Exercise-Induced Vasospastic Angina With Ventricular Fibrillation. [PDF]

JACC Case Rep
Aikawa H, Murai K, Seiki S, Sawano H, Kobayashi M, Hirooka K, Hayashi Y, Ito Y.   +7 more
europepmc   +1 more source

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). I. Treatments in preclinical and early clinical development

Epilepsia, EarlyView.
Abstract Over the last 34 years, the Eilat Conference on New Antiepileptic Drugs and Devices has provided an interactive forum for stakeholders to discuss investigational and recently licensed treatments for seizures and epilepsy. The Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII) took place in Madrid, Spain, on May 3 ...
Meir Bialer, Cecilie Johannessen Landmark, Matthias J. Koepp, Emilio Perucca, Piero Perucca, Torbjörn Tomson, H. Steve White, Elaine Wirrell   +7 more
wiley   +1 more source

Prolonged fenfluramine use in open‐label studies of Dravet or Lennox–Gastaut syndromes: Long‐term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness

Epilepsia, EarlyView.
This graphical abstract provides an overview of the content from this open‐label extension study of fenfluramine use in patients with Dravet syndrome or Lennox‐Gastaut syndrome. Abstract Objective Long‐term safety and global functioning are reported in patients with Dravet syndrome (DS) or Lennox–Gastaut syndrome (LGS) treated with fenfluramine in an ...
Antonio Gil‐Nagel, Kelly G. Knupp, Boudewijn Gunning, Domenica Immacolata Battaglia, Elizabeth A. Thiele, Ingrid E. Scheffer, An‐Sofie Schoonjans, Rima Nabbout, Nathalie Villeneuve, Kerstin Alexandra Klotz, Nicola Specchio, Rocio Sanchez‐Carpintero, Marta Zolnowska, Anne‐Liv Schulz, Lily Perrin, Najla Dickson, Mélanie Langlois, Amélie Lothe, Joseph Sullivan   +18 more
wiley   +1 more source

Multimodal Prediction of Progression Toward Brain Death After Out-of-Hospital Cardiac Arrest. [PDF]

J Clin Med
Oh JH, Kim J, Zhu JH, Kwon MK, Choi SP, Kim HJ, Kim K, Song H, Kim SH, Crown Investigators.   +9 more
europepmc   +1 more source

Outcomes of In-hospital Cardiac Arrest: Insights from a Medical Intensive Care Unit. [PDF]

PLoS One
Kailasam K, Alwakeel M, Wang X, Duggal A, Krishnan S.   +4 more
europepmc   +1 more source

Pharmacological mechanisms and clinical evidence of vasopressin, steroids, and epinephrine triple therapy in in-hospital cardiac arrest. [PDF]

Front Cardiovasc Med
Ma C, Wang T, Zhou Y, Wang N, Lan C.
europepmc   +1 more source